Navigation Links
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Date:8/20/2007

at all, the risk that Soliris will not generate interest among physicians, the risk that estimates regarding the number of PNH patients are inaccurate, the risk that pending litigation may be resolved adversely, and a variety of other risks set forth from time to time in Alexion's filings with the Securities and Exchange Commission, including but not limited to the risks discussed in Alexion's Quarterly Report on Form 10-Q for the period ended June 30, 2007 and in our other filings with the Securities and Exchange Commission. Alexion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof, except when a duty arises under law.

(1) Rother R, Bell L, Hillmen P, Gladwin M. The clinical sequelae of

intravascular hemolysis and extracellular plasma hemoglobin. JAMA

2005; 293:1653-1662.

(2) Parker C, Omine M, Richards S, et al. Diagnosis and management of

paroxysmal nocturnal hemoglobinuria. Blood 2005; 106:3699-3709.

(3) Socie G, Mary J Yves, de Gramont A, et al. Paroxysmal nocturnal

haemoglobinuria: long-term follow-up and prognostic factors. Lancet

1996; 348:573-577.

(4) Hillmen P. Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history

of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;

333:1253-1258.

(5) Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of

paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.

Br J Haematol. 2004;126:133-138.

(6) Araten DJ, Thaler HT, Luzzatto L. High incidence of thrombosis in

African-American and Latin-American patients with Paroxysmal

Nocturnal Haemoglobinuria. Thromb Haemost. 2005;93:88-91.

(7) Nishimura J, Kanakura Y, Ware RE et al. Clinical course and flow

cytometric analysis of paroxysmal nocturnal hemoglobinuria in the

United States and J
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
2. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Mass. , May 29, 2015  Hologic, Inc. ... has entered into a new, five-year secured credit agreement ... a $1 billion revolving credit facility. Hologic ... and used these proceeds and the Term Loan to ... which had an aggregate principal amount outstanding of $1.69 ...
(Date:5/29/2015)... 29, 2015  Today, UL LLC, a global ... provider of electronic quality management systems (EQMS) and ... will leverage the strengths of both organizations to ... implementation and comprehensive advice and guidance for successful ... capabilities to UL,s strength in regulatory services and ...
(Date:5/29/2015)... Fla. , May 29, 2015  Excite Medical ... in 2007.  Over the years, Excite Medical, under the ... be an enduring company, with a solid track record ... and growing client and distributor base.  ... success of Excite Medical has been possible, in large ...
Breaking Medicine Technology:Hologic Enters into Five-Year Secured Credit Agreement 2Hologic Enters into Five-Year Secured Credit Agreement 3UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3
... Conatus Pharmaceuticals Inc. today announced the closing of ... financing.  This financing was led by new investor, AgeChem ... existing investors; Aberdare Ventures, Advent Venture Partners, Bay City ... will use the proceeds to advance the clinical development ...
... Mindray Medical International Limited (NYSE: MR), a leading developer, ... that it will report its financial results for the ... market closes on February 28, 2011. Mindray,s management will ... March 1, 2011 U.S. Eastern Time (9:00 PM on ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011 2
(Date:5/29/2015)... 29, 2015 On May 21, 2015, Elle ... When You Get Botox ?” reported on the four ... Elle partnered with Google to determine these results and then ... question in California, for example, is how to keep ... search query is what's the appropriate age to start receiving ...
(Date:5/29/2015)... May 29, 2015 Jan Wooden Howse lost ... one thing above all else: God does no wrong. , ... of her son’s passing is titled “God Does No Wrong.” ... confronted with great personal tragedy. , “My story has ... dear to you into something productive, something healing,” Howse said. ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
(Date:5/29/2015)... Diego, California (PRWEB) May 29, 2015 A ... Core” and have joined the national effort to teach this ... parents in the U.S. have been “sickened” by the recent ... However, love it or hate it, Common Core is now ... District of Columbia. Parents are now seeking ways to ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... recently partnered with Stratus Video Interpreting ... will facilitate better communication and timely care ... and hearing loss. Stratus’ video remote interpreting ... translators, enabling staff to quickly access qualified ...
Breaking Medicine News(10 mins):Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... an assistant professor at the University of Miami, School ... grant from the Robert Wood Johnson Foundation (RWJF) to ... dating violence among Hispanics. Gonzalez-Guarda is one of just ... the three-year $350,000 Nurse Faculty Scholar award this year. ...
... , WEDNESDAY, Sept. 7 (HealthDay News) -- Breast-feeding ... mothers who bottle-feed or women without children, researchers say. ... mothers and 20 non-mothers also found that aggression in ... This suggests that breast-feeding helps lower the body,s typical ...
... who have received high doses of chemotherapy may find ... research from the Sahlgrenska Academy at the University of ... chemotherapy treatment were two times higher than among those ... the scientific journal Acta Oncologica . Almost one ...
... concerns may prevent children from getting good exercise, according ... examined how families use neighborhood parks. Results ... too closely by hovering "helicopter" parents were less likely ... "It,s a catch-22 for today,s parents, unfortunately. Many ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, Sept. ... jeopardize their children,s academic success and harm their family,s finances ... money on cigarettes, according to a new study. The ... with smokers have higher rates of respiratory illness and missed ...
... Reporter , TUESDAY, Sept. 6 (HealthDay News) -- Contrary ... and breast self-exams are useful for the detection of ... screening mammographies and evaluations of palpable masses are important ... co-author of a study to be presented at the ...
Cached Medicine News:Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 2Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 3Health News:Chemotherapy can impair speech 2Health News:Helicopter parents can impede child’s ability to play 2Health News:Parents Who Smoke at Home May Risk Kids' Academic Success 2Health News:Parents Who Smoke at Home May Risk Kids' Academic Success 3Health News:Annual Breast Exams, Mammograms Still Key to Detecting Breast Cancer 2Health News:Annual Breast Exams, Mammograms Still Key to Detecting Breast Cancer 3
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint ... align the hand with ulnar deviation at ... impede grasp or pinch. Radial and ulnar ... ensure unimpeded flexion and extension. Padded, malleable ...
... immobilizes and positions the elbow at 122 ... prominent. Restricts full extension and flexion to ... helps prevent pain and irritation due to ... post-cast removal. Rigid, high-density beige polyethylene shell ...
... Orthosis For quick, efficient immobilization of ... immobilizes and protects the fracture and ... comfort, support, and conformity to the ... shell may be gently heated (with ...
Medicine Products: